Has Matthew Bergsten, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,730 in general payments to Matthew Bergsten, MD across 235 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Bergsten, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Bergsten, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Bergsten, MD

Pain Medicine · Albuquerque, NMNPI 1093134983

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,991 of the $6,730 with a category attached, or 74.2%. 15 manufacturers reported payments, led by Abbott at 49.5% of the total. Reporting peaked in 2019 at $2,169 and has fallen 75.7% since, to $527 in 2025.

$6,730in general payments, 2019–2025

Across 235 payments — averaging $28.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$3K
Medtronic$2K
AbbVie$782
Scilex Pharmaceuticals Inc.$286
Biodelivery Sciences International, Inc.$150
Si-bone, Inc.$122
plus $367 from 9 others

What the payments were for

Grants$1,66725%
Travel & lodging$731%
Food & beverage$4,99174%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	135	$3,330
Medtronic(2 entities)	2	$1,693
AbbVie(2 entities)	47	$782
Scilex Pharmaceuticals Inc.	16	$286
Biodelivery Sciences International, Inc.	14	$150
Si-bone, Inc.	2	$122
Lilly USA, LLC	8	$119
Biohaven Pharmaceuticals, Inc.	2	$54
Pacira Therapeutics, Inc.	2	$53
Lundbeck LLC	2	$46
Boston Scientific	1	$29
Fidia Pharma USA Inc.	1	$20
Avanos Medical	1	$17
Ferring Pharmaceuticals Inc.	1	$15
Curonix LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,730 in reported general payments places this provider in the 85th percentile of 36 pain medicine providers in New Mexico.

See all pain medicine providers in New Mexico →

Medicare billing

Part B allowed, 2024

$154,756

Medicare patients

190

Services billed

3,463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BelbucaBuprenorphine Hcl	39	$34,240
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	53	$20,633
Pregabalin	361	$9,541
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	301	$7,444
Gabapentin	400	$7,112
Buprenorphine	20	$6,330
Buprenorphine Hcl	125	$6,147
Ondansetron OdtOndansetron	17	$4,190
Acetaminophen-CodeineAcetaminophen With Codeine	103	$2,596
Tramadol Hcl ErTramadol Hcl	22	$2,400
Tramadol Hcl	180	$2,313
Tizanidine Hcl	132	$1,671
Ondansetron Hcl	47	$1,596
Celecoxib	45	$1,393
Naloxone Hcl	20	$1,348

Paid to pharmacies, not to this prescriber.

Other pain medicine in Albuquerque

John WatkinsAlbuquerque$22K
Craig RumbaughAlbuquerque$11K
Eugene KoshkinAlbuquerque$10K
Lauren HarrisAlbuquerque$6K
Melissa MerhegeAlbuquerque$5K
Jeremy ChastainAlbuquerque$5K
Joshu RaitenAlbuquerque$4K
Thomas WhalenAlbuquerque$4K
Matthew ValerianoAlbuquerque$4K
Umar CheemaAlbuquerque$4K

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →